β-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection

American Journal of Hypertension

Volumn 21, Issue 6, 2008, Pages 663-667

  Mahmud, Azra ^a   Feely, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NEBIVOLOL; VASODILATOR AGENT;

ADULT; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FEMORAL ARTERY; HEART HEMODYNAMICS; HEART RATE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; TONOMETRY; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; AORTA; ATENOLOL; BENZOPYRANS; BLOOD PRESSURE; ETHANOLAMINES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VASODILATION;

EID: 44349118138     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2008.156     Document Type: Article

References (17)

1. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
2. Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther 2003; 1:89-102.
3. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
4. Kelly RP, Daley J, Avolio A, O'Rourke MF. Arterial dilatation and reduced wave reflection: benefit of dilevalol in hypertension. Hypertension 1989; 14:14-21.
5. Chen CH, Ting C-T, Lin SJ, Hsu TL, Yin ICP, Siu CO. Different effects of fosinopril and atenolol on wave reflection in hypertension patients. Hypertension 1995; 25:1034-1041.
6. Asmar RG, London GM, O'Rourke ME, Mallion JM, Romero R, Rahn KH, Trimarco B, Fitzgerald D, Hedner T, Duprez D, De Leeuw PW, Sever P, Battegay E, Hitzenberger G, De Luca N, Benetis A, Chastang C, Ollivier JP, Safar ME; REASON Project Investigators. Amelioration of arterial properties with a perindopril-indapamide very low dose combination. J Hypertens 2001; 19(Suppl 4):S15-S20.
7. Tzemos N, Lim PO, MacDonald TM. Nobivolol reverses endothelial dysfunction in essential hypertension: a randomised, double blind, crossover study. Circulation 2001; 104:511-514.
8. Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim I, Sezgin AT, Muderrisoglu H. Different effects of atenolol and nebivolol on coronary flow reserve. Heart 2006; 92:1690-1691.
9. Dhakam Z, Yasmin., McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008; 26:351-356.
10. Kamp O, Sieswerda GT, Visser CA. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension. Am J Cardiol 2003; 92:344-348.
11. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h P-M, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735-738.
12. Papaioannou TG, Vlachopoulos CV, Alexopoulos NA, Dima I, Pietri PG, Protogerou AD, Vyssoulis GG, Stefanadis CI. The effect of heart rate on wave reflections may be determined by the level of aortic stiffness: clinical and technical implications. Am J Hypertens, this issue.
13. Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, Van Nueten L, Wooding SJ, Ritter JM. Nebivolol vasodilates human forearm vasculature: evidence for an l-arginine/NO-dependent mechanism. J Pharmacol Exp Therap 1995; 274:1067-1071.
14. Maffei A, Pardo AD, Carangi R, Carullo P, Poulet R, Gentile MT, Vecchione C, Lembo G. Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation. Hypertension 2007; 50:652-656.
15. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A,Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J,Tavazzi L, Spinarova L, Toman J, Bahm M, Anker SD, Thompson SG, Poole-Wilson PA; SENIORS Investigators. Randomised trial to determine the effect of nebivolol onmortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26:215-225.
16. McEniery CM, Schmitt M, Qasem A, Webb DJ, Avolio AP, Wilkinson IB, Cockcroft JR. Nebivolol increases arterial distensibility in vivo. Hypertension 2004; 44:305-310.
17. Arosio E, De Marchi S, Prior M, Zannoni M, Lechi A. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress. J Hypertens 2002; 20:1793-1797.